Literature DB >> 10744749

The human T cell leukemia/lymphotropic virus type 1 Tax protein represses MyoD-dependent transcription by inhibiting MyoD-binding to the KIX domain of p300. A potential mechanism for Tax-mediated repression of the transcriptional activity of basic helix-loop-helix factors.

P Riou1, F Bex, L Gazzolo.   

Abstract

The human T cell leukemia/lymphotropic virus type 1 (HTLV-1) Tax protein strongly activates viral and cellular gene transcription. It mainly functions by interacting with cellular transcription factors and the KIX domain of the p300/CBP coactivators. Tax can also repress the transcription of cellular genes through the basic helix-loop-helix (bHLH) protein family. To investigate the molecular mechanisms of this Tax-mediated inhibition, we analyzed its effect on the transcriptional activity of the myogenic MyoD protein, which was used as a paradigm of bHLH factors. In this study, we show that overexpression of the p300 coactivator in transient transfection assays was sufficient to rescue MyoD repression by Tax. Furthermore, an N-terminal domain of p300 (amino acids 379-654) containing the region of KIX serving as the Tax binding site was found, when overexpressed, to potentiate Tax-mediated transactivation of HTLV-1 proviral as well as MyoD-dependent transcription, and to antagonize the inhibition by Tax of the transcriptional activity of MyoD. These results revealing the presence of an N-terminal MyoD binding site were confirmed by in vitro protein-protein interaction assays that demonstrate that MyoD binds to the KIX domain of p300 and that Tax competes with MyoD binding in a nonreciprocal manner. These observations provide evidence that Tax binding to the KIX domain of p300 prevents bHLH proteins from contacting this N-terminal domain of the coactivator, thus resulting in their transcriptional repression. As bHLH proteins are implicated in many developmental fate decisions, especially during thymopoiesis, Tax-mediated inhibition of their transcriptional activity may contribute to the induction of HTLV-1-linked leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744749     DOI: 10.1074/jbc.275.14.10551

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein.

Authors:  P Ernst; J Wang; M Huang; R H Goodman; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

Review 2.  Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2.

Authors:  Gerold Feuer; Patrick L Green
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

3.  Differential effects of HTLV-1 Tax oncoprotein on the different estrogen-induced-ER α-mediated transcriptional activities.

Authors:  Ammar Abou-Kandil; Nora Eisa; Azhar Jabareen; Mahmoud Huleihel
Journal:  Cell Cycle       Date:  2016-07-15       Impact factor: 4.534

4.  Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34+) cells: modulation of p21cip1/waf1 and p27kip1 expression.

Authors:  Adam Tripp; Prabal Banerjee; Michelle Sieburg; Vicente Planelles; Fengzhi Li; Gerold Feuer
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  CREB/ATF-dependent repression of cyclin a by human T-cell leukemia virus type 1 Tax protein.

Authors:  K V Kibler; K T Jeang
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Human T-cell leukemia virus type 1 Tax protein down-regulates pre-T-cell receptor alpha gene transcription in human immature thymocytes.

Authors:  Mélanie Wencker; Céline Sausse; David Derse; Louis Gazzolo; Madeleine Duc Dodon
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

7.  CBP/p300 and muscle differentiation: no HAT, no muscle.

Authors:  A Polesskaya; I Naguibneva; L Fritsch; A Duquet; S Ait-Si-Ali; P Robin; A Vervisch; L L Pritchard; P Cole; A Harel-Bellan
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

Review 8.  Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.

Authors:  M Matsuoka; K-T Jeang
Journal:  Oncogene       Date:  2010-11-29       Impact factor: 9.867

Review 9.  Hematopoietic stem cells and retroviral infection.

Authors:  Prabal Banerjee; Lindsey Crawford; Elizabeth Samuelson; Gerold Feuer
Journal:  Retrovirology       Date:  2010-02-04       Impact factor: 4.602

10.  Cross talk between expression of the human T-cell leukemia virus type 1 Tax transactivator and the oncogenic bHLH transcription factor TAL1.

Authors:  Jean-Michel Terme; Melanie Wencker; Arnaud Favre-Bonvin; Françoise Bex; Louis Gazzolo; Madeleine Duc Dodon; Pierre Jalinot
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.